The antibiotic albocycline blocks the synthesis of nicotinate or nicotinamide in Bacillus subtilis cells. The inhibitory activity of the agent is fully reversed by nicotinic acid, nicotinamide, and, to a moderate extent, also by quinolinate. This suggests that in B. subtilis the antibiotic interferes with a reaction step occurring prior to the formation of quinolinate within the biosynthetic pathway leading to nicotinate. The results presented in this paper show that the inhibitory activity of albocycine is fully reversed in Bacillus subtilis cells by the addition of nicotinate, nicotinamide, and, to a moderate extent, also by quinolinate.
Albocycline has a very low solubility in water (10 to 20 ,ug/ml), but is soluble in most organic solvents. The antibiotic crystallizes in the form of colorless plates and has the empirical formula C18H2804. The The results presented in this paper show that the inhibitory activity of albocycine is fully reversed in Bacillus subtilis cells by the addition of nicotinate, nicotinamide, and, to a moderate extent, also by quinolinate.
MATERIALS AND METHODS Cells of B. subtilis strain 23 were grown in a glucose-salt medium described previously (5) . Shaken flasks containing 100 ml of medium were inoculated with 5 ml of seed derived from an overnight culture. The flasks were incubated on a rotary shaker at 37 C. Albocycline was dissolved in dimethylformamide and was added in 0.1-ml portions per 100 ml of culture medium. Cell growth was assessed by measuring the optical density of the bacterial suspensions at 570 nm.
Total nicotinic acid present in the cultures was assayed microbiologically (5) . Preparation and assay of quinolinate phosphoribosyltransferase were described previously (5).
RESULTS
The effect of different albocycline concentrations in exponentially growing B. subtilis cells is shown in Fig. 1 . At albocycline concentrations ranging from 0.5 to 5 ,ug/ml, cell growth remained unaffected for approximately 30 min following addition of the antibiotic. After this time, growth ceased abruptly in the presence of 5 ,ug/ml of drug. Concentrations of 0.5 to 2 jig/ml caused correspondingly less inhibition.
Albocycline did not interfere with macromolecular biosynthetic processes (nucleic acid, protein synthesis) in bacterial cell-free systems prepared according to the method of Reusser (4) .
On the other hand, it was found that nicotinate effectively reversed albocycline inhibition in B. subtilis. In the presence of a constant amount of albocycline (5 jAg/ml), an amount of 1 ,Ag/ml of nicotinate caused full reversal of albocycline inhibition as shown in Fig. 2 When the concentration of albocycline was varied in the presence of a constant amount of nicotinate (1 ,Ag/ml), cell growth remained completely unaffected by albocycline present in concentrations from 5-20 jug/ml (Fig. 3) . Fifty JAg/ml of albocycline caused only moderate inhibition.
Addition of nicotinate from 0 to 60 min after exposure of the cells to albocycline resulted in an immediate resumption of growth (Fig. 4) Nicptinamide reversed growth inhibition induced by albocycine as effectively as nicotinate. Nicotinamide adenine dinucleotide (NAD) or reduced NAD (NADH) caused substantial reversal only after prolonged incubation of the cultures (12 to 16 hr). L-Kynurenine, L-3-hydroxykynurenine, and 3-hydroxyanthranilic acid did not cause any reversi of albocycline activity. Quinolinic acid caused some reversal but only after prolonged incubation of the cultures ( Table  1 ). The extent of reversal obtained was dependent on the concentration of quinolinate present.
Cell growth and net nicotinic acid biosynthesis were measured simultaneously in the presence or absence of albocycline. In the presence of 10 ,ug/ml of albocycine moderate cell growth was apparent for 2 hr following addition of the drug, but nicotinic acid biosynthesis ceased immediately after addition of antibiotic (Fig. 5 ).
Quinolinic acid phosphoribosyl transferase In animals and fungi, nicotinate arises from tryptophan as a precursor. Several intermediates occurring within the tryptophan pathway (L-kynurenine, 3 -hydroxykynurenine, 3-hydroxyanthranilic acid) did not cause reversal of albocycline inhibition in B. subtilis. In most bacteria, nicotinate is formed via the condensation of a fourcarbon dicarboxylic acid (succinate, aspartate) with a three-carbon compound (glycerol). One or several unknown steps lead to the formation of quinolinate which is then converted to nicotinate ribonucleotide and eventually to NAD, as shown in the scheme below (2, 3): In a recent paper, we reported that the sulfurcontaining antibiotic melinacidin acts as a very potent inhibitor of nicotinate biosynthesis in bacteria by blocking a reaction step presumably occurring prior to the formation of quinolinate nicotinic acid -- 
